Complications of levodopa therapy in Parkinson's disease

被引:2
|
作者
Dubow, Jordan [1 ]
Olanow, C. Warren [2 ]
机构
[1] Avadel Pharmaceut PLC, Chesterfield, MO 63005 USA
[2] Mt Sinai Hlth Syst, Dept Neurol & Neurosci, New York, NY USA
来源
EXPERT OPINION ON ORPHAN DRUGS | 2019年 / 7卷 / 09期
关键词
Parkinson's disease; motor complications; dyskinesia; wearing off; levodopa; EXTENDED-RELEASE CAPSULES; CARBIDOPA INTESTINAL GEL; PLACEBO-CONTROLLED TRIAL; DEEP-BRAIN-STIMULATION; DOUBLE-BLIND; MOTOR FLUCTUATIONS; INDUCED DYSKINESIA; WEARING-OFF; DOPAMINE; ISTRADEFYLLINE;
D O I
10.1080/21678707.2019.1662294
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Levodopa remains the most effective treatment for the motor symptoms of Parkinson's disease (PD). However, with chronic treatment, PD patients develop motor complications, which consist of motor fluctuations and dyskinesia. Many new treatments, both medical and interventional, have been developed for the treatment of motor complications but there continues to be an unmet medical need for further treatments. Areas covered: This manuscript summarizes the phenomenology, pathophysiology, prevalence and current and future treatments of motor complications in PD patients based on a PubMed literature search from 1950s to present. Expert opinion: Motor complications are prevalent in PD and risk factors for developing these complications are well-known and well characterized. There are many effective medical and interventional treatments for both motor fluctuations and dyskinesia in PD patients. Despite these treatments, many patients still suffer from many hours of 'Off' time or dyskinesia that have a profound negative impact on quality of life. There are many exciting treatments under development for motor complications that may provide additional benefit for PD patients.
引用
收藏
页码:391 / 397
页数:7
相关论文
共 50 条
  • [21] The impact of levodopa therapy-induced complications on quality of life in Parkinson’s disease patients in Singapore
    Jonathan Wu
    Ee-Chien Lim
    Nivedita V. Nadkarni
    Eng-King Tan
    Prakash M. Kumar
    [J]. Scientific Reports, 9
  • [22] Evidence for association of high-dose levodopa therapy with intellectual and psychiatric complications of Parkinson's disease
    Hamza, T.
    Factor, S.
    Molho, E.
    Montimurro, J.
    Pratt, D.
    Rosen, A.
    Higgins, D.
    Payami, H.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S119 - S119
  • [23] Gene therapy for Parkinson's disease: An approach to the prevention or palliation of levodopa-associated motor complications
    Mouradian, MM
    Chase, TN
    [J]. EXPERIMENTAL NEUROLOGY, 1997, 144 (01) : 51 - 57
  • [24] Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson's disease patients with motor complications
    Stowe, Rebecca
    Ives, Natalie
    Clarke, Carl E.
    Deane, Katherine
    van Hilten
    Wheatley, Keith
    Gray, Richard
    Handley, Kelly
    Furmston, Alex
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (07):
  • [25] Levodopa and Parkinson's disease
    Valkovic, P.
    Blazicek, P.
    Benetin, J.
    Kukumberg, P.
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2006, 69 (03) : 183 - 188
  • [26] Levodopa therapy for Parkinson's disease: Challenges and future prospects
    Olanow, C. Warren
    Lees, Andrew
    Obeso, Jose
    [J]. MOVEMENT DISORDERS, 2008, 23 : S495 - S496
  • [27] Does levodopa therapy delay death in Parkinson's disease?
    Uitti, RJ
    Ahlskog, JE
    Maraganore, DM
    [J]. MOVEMENT DISORDERS, 1996, 11 (03) : 343 - 344
  • [28] Effects of intraduodenal levodopa infusion therapy on Parkinson's disease
    Tomantschger, V.
    Tautscher-Basnett, G.
    Freimueller, M.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S431 - S431
  • [29] Value of Levodopa Therapy for Early and Advanced Parkinson's Disease
    Baas, H.
    Hagenah, J.
    Hahne, M.
    Redecker, C.
    Wojtecki, L.
    Wuellner, U.
    [J]. AKTUELLE NEUROLOGIE, 2013, 40 (06) : 338 - 342
  • [30] Novel Approaches to Optimization of Levodopa Therapy for Parkinson's Disease
    Kianirad, Yasaman
    Simuni, Tanya
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (04) : 1 - 6